ATRA sensitized the response of hepatocellular carcinoma to Sorafenib by downregulation of p21-activated kinase 1

BACKGROUND: Sorafenib resistance greatly reduces the efficacy of treatments in advanced hepatocellular carcinoma (HCC) patients, but the underlying mechanisms are not thoroughly understood. All-trans retinoic acid (ATRA), an anti-leukaemia agent, has attracted considerable attention due to its role...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Kai, Qiu, Xun, Zhang, Zhensheng, Xu, Hanzhi, Tan, Yawen, Su, Renyi, Gao, Fengqiang, Zhuo, Jianyong, Li, Wangyao, Lian, Zhengxing, He, Hong, Xu, Xiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10399044/
https://www.ncbi.nlm.nih.gov/pubmed/37537668
http://dx.doi.org/10.1186/s12964-023-01194-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10399044/
https://www.ncbi.nlm.nih.gov/pubmed/37537668
http://dx.doi.org/10.1186/s12964-023-01194-1

Ejemplares similares